PetMed Express (PETS) Tops Q3 Earnings Views
More News related to PETS
- PetMed Express D/B/A 1-800-PetMeds Announces Its Quarterly Dividend
- Wedbush Maintains a 'Neutral' on PetMed Express (PETS); Lowers Price Target
- Unusual 11 Mid-Day Movers 10/19: FIGI, IPCS, BEST, AMPL Higher; FNM, FRE, IDCC, PETS Lower
- PetMed (PETS) Shares Trade Lower This Morning on Lower Revenue
- Morning Movers 10/19: FIGI, IPCS, BEST, ALLI, CIT Higher; JACO, FNM, IDCC, FRE, PETS Lower
More News related to Earnings
- Credit Suisse Raises Rating on European Equities from Underweight to Overweight
- Canaccord Adams Upgrades Pan American Silver (PAAS) to Buy
- National Bank Upgrades Pengrowth Energy (PGH) to Outperform
- Ardour Capital Upgrades Capstone Turbine (CPST) to Accumulate
- Global Hunter Securities Upgrades Petroleum Development Corp. (PETD) to Buy
PetMed Express, Inc. (NASDAQ: PETS) reports Q3 EPS of $0.21, 1 cent better than the analyst estimate of $0.20. Revenue for the quarter was $43.4 million, versus the consensus of $42.86 million.
PetMed Express, Inc., doing business as 1-800-PetMeds, engages in the marketing and sale of prescription and non-prescription pet medications, and other health products for dogs, cats, and horses.
Related Categories
EarningsStocks Mentioned
-0.05Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
